Veliparib and Dinaciclib in Treating Patients With Advanced Solid Tumors

NCT01434316 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

121

Enrollment

NIH

Sponsor class

Conditions

Advanced Malignant Solid Neoplasm

Interventions

DRUG: Dinaciclib
DRUG: Veliparib

Sponsor

National Cancer Institute (NCI)